Jonathan Strober, MD, discusses advancements in pediatric myasthenia gravis, emphasizing the need for better treatment standards and effective patient care strategies.
Regeneron is finding ways to deal with the increased competition to one of its key growth drivers. The company is also ...
Investor's Business Daily on MSN
Eli Lilly leads five stocks near buy points in divided market
Eli Lilly, United Airlines and Urban Outfitters lead five stocks that are showing strength, near buy points, as AI stocks ...
Horsham: Johnson & Johnson has announced the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback